Last reviewed · How we verify
Tissue Plasminogen Activator — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Tissue Plasminogen Activator (Tissue Plasminogen Activator) — Brigham and Women's Hospital.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Tissue Plasminogen Activator TARGET | Tissue Plasminogen Activator | Brigham and Women's Hospital | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Tissue Plasminogen Activator CI watch — RSS
- Tissue Plasminogen Activator CI watch — Atom
- Tissue Plasminogen Activator CI watch — JSON
- Tissue Plasminogen Activator alone — RSS
Cite this brief
Drug Landscape (2026). Tissue Plasminogen Activator — Competitive Intelligence Brief. https://druglandscape.com/ci/tissue-plasminogen-activator. Accessed 2026-05-15.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab